These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 21272576)

  • 21. Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.
    Quigley HA; Pitha IF; Welsbie DS; Nguyen C; Steinhart MR; Nguyen TD; Pease ME; Oglesby EN; Berlinicke CA; Mitchell KL; Kim J; Jefferys JJ; Kimball EC
    PLoS One; 2015; 10(10):e0141137. PubMed ID: 26505191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
    Mammone T; Chidlow G; Casson RJ; Wood JPM
    Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma.
    Cone FE; Steinhart MR; Oglesby EN; Kalesnykas G; Pease ME; Quigley HA
    Exp Eye Res; 2012 Jun; 99(1):27-35. PubMed ID: 22554836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.
    Zhu Y; Zhang L; Sasaki Y; Milbrandt J; Gidday JM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):25-36. PubMed ID: 23211826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration.
    Syc-Mazurek SB; Fernandes KA; Libby RT
    Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension.
    Marina N; Sajic M; Bull ND; Hyatt AJ; Berry D; Smith KJ; Martin KR
    Exp Eye Res; 2012 Nov; 104():1-6. PubMed ID: 22982756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse model of elevated intraocular pressure: retina and optic nerve findings.
    Gross RL; Ji J; Chang P; Pennesi ME; Yang Z; Zhang J; Wu SM
    Trans Am Ophthalmol Soc; 2003; 101():163-9; discussion 169-71. PubMed ID: 14971574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
    Ebneter A; Chidlow G; Wood JP; Casson RJ
    Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma.
    Nguyen C; Cone FE; Nguyen TD; Coudrillier B; Pease ME; Steinhart MR; Oglesby EN; Jefferys JL; Quigley HA
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1767-80. PubMed ID: 23404116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.
    McDowell CM; Luan T; Zhang Z; Putliwala T; Wordinger RJ; Millar JC; John SW; Pang IH; Clark AF
    Exp Eye Res; 2012 Jul; 100():65-72. PubMed ID: 22575566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.
    Chen H; Wei X; Cho KS; Chen G; Sappington R; Calkins DJ; Chen DF
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):36-44. PubMed ID: 20702815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged elevation of intraocular pressure results in retinal ganglion cell loss and abnormal retinal function in mice.
    Khan AK; Tse DY; van der Heijden ME; Shah P; Nusbaum DM; Yang Z; Wu SM; Frankfort BJ
    Exp Eye Res; 2015 Jan; 130():29-37. PubMed ID: 25450059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental scleral cross-linking increases glaucoma damage in a mouse model.
    Kimball EC; Nguyen C; Steinhart MR; Nguyen TD; Pease ME; Oglesby EN; Oveson BC; Quigley HA
    Exp Eye Res; 2014 Nov; 128():129-40. PubMed ID: 25285424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1.
    Ha Y; Saul A; Tawfik A; Zorrilla EP; Ganapathy V; Smith SB
    Mol Vis; 2012; 18():2860-70. PubMed ID: 23233788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
    Guo Y; Johnson E; Cepurna W; Jia L; Dyck J; Morrison JC
    Exp Eye Res; 2009 Dec; 89(6):921-33. PubMed ID: 19682984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure.
    Joos KM; Li C; Sappington RM
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6431-40. PubMed ID: 20688743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of a dual ET
    Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
    Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.
    Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2051-9. PubMed ID: 19933193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy in the Aging and Experimental Ocular Hypertensive Mouse Model.
    Nettesheim A; Dixon A; Shim MS; Coyne A; Walsh M; Liton PB
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):31. PubMed ID: 32797200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.